UNSPSC 51152075: Vecuronium bromide

This classification denotes a muscle relaxant with the molecular formula C34H57N2O4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E4PHP5N1D, chemically known as 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate but more generally known as vecuronium bromide, which bears US NIH Compound Identifier 39764. European Medicines Agency schedules Vecuronium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00029MIG.

UNSPSC 51152075 Vecuronium bromide is a Commodity code that nominally covers a specific neuromuscular-blocking agent used in anesthesia and critical care. However, the most recent state and local procurement activity flagged under this code does not align with the code's intended scope — Seminole County, Florida posted an IFB for naloxone and safe drug deactivation systems, which fall outside the pharmaceutical class and clinical application of vecuronium bromide. The mismatch suggests either a coding error in the county's procurement system or a deliberate misclassification for administrative reasons.

The single recent opportunity on record is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (note: the dates appear inconsistent in the source). The solicitation seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs, hold drug-free workplace certification, and comply with E-Verify requirements. The contract runs two years with a one-year renewal option and carries potential FEMA funding with associated federal compliance obligations. Given the single opportunity and the mismatch between the code's pharmaceutical intended use and the naloxone procurement actually posted, this code shows little relevant recent state and local activity for vendors pursuing vecuronium bromide or related neuromuscular-blocking agents.